Aurobindo Pharma gains 12% after USFDA issued EIR for Hyderabad facility

The stock is trading higher for the fourth straight day and has rallied 38 per cent during the period.

The stock is trading higher for the fourth straight day and has rallied 38 per cent during the period. https://ift.tt/2Jf6Qia March 26, 2020 at 08:25PM

Comments

Popular posts from this blog

US may impose tariffs on India, Italy for taxing internet firms like Google

No locus standi: India rejects US global religious freedom report